eCoin
Commercial- Indications
- Urinary incontinence, Overactive bladder
Company intelligence / Profile preview
Valencia Technologies has developed the eCoin system, a minimally invasive implantable neurostimulator for treating urge urinary incontinence. The device is implanted near the ankle and delivers automatic periodic stimulation to the tibial nerve. Clinical results have shown benefit for patients with urge urinary incontinence, with streamlined post-procedure management compared to other devices. The company recently secured $35 million investment to accelerate commercialization under new CEO James D. Surek.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VALENCIARTE.